An aircraft having vertical takeoff and landing capability provided with at least first and second laterally extending paddle wheels rotatable on a central axis perpendicular to the longitudinal axis of the aircraft fuselage and between its nose and tail.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7427487 | Constitutively active CXCR3 G protein-coupled chemokine receptor and modulators thereof for the treatment of inflammatory disorders The invention disclosed in this patent document relates to transmembrane receptors, particularly to a human G protein-coupled receptor, more particularly to a CXC chemokine receptor subtype 3 (CXCR3), and most particularly to mutated (non-endogenous) version of the ... | 09/23/2008 |
| 7425630 | Processes for preparing pyrazolo[3,4-d]pyrimidine ethers The present invention relates to processes for preparing pyrazolo[3,4-d]pyrimidine ether compounds that are modulators of glucose metabolism and therefore useful in the treatment of metabolic disorders such as diabetes and obesity. ... | 09/16/2008 |
| 7410777 | Non-endogenous, constitutively activated human G protein-coupled receptors Disclosed herein are constitutively activated, non-endogenous versions of endogenous human G protein-coupled receptors comprising (a) the following amino acid sequence region (C-terminus to N-terminus orientation) and/or (b) the following nucleic acid sequence regio... | 08/12/2008 |
| 7381522 | Non-endogenous, constitutively activated known G protein-coupled receptors The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor for which the endogenous ligand is known (“known GPCRs”), and most particularly to mutated (non-endogenous) versions of th... | 06/03/2008 |
| 7368539 | Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof Disclosed herein are non-endogenous, constitutively activated forms of the human 5-HT2A and human 5-HT2C receptors and uses of such receptors to screen candidate compounds. Further disclosed herein are candidate compounds identified by the scre... | 05/06/2008 |
| 7241792 | Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof The present invention relates to certain fused pyrazole derivatives of Formula (Ia), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. | 07/10/2007 |
| 6107324 | 5-HT2A receptor inverse agonists Disclosed herein is a new class of pyrazole compounds which act at the 5HT2A receptors.... | 08/22/2000 |